The aberrant epigenome of DNMT3B -mutated ICF1 patient iPSCs is amenable to correction, with the exception of a subset of regions with H3K4me3- and/or CTCF-based epigenetic memory
Genome Research · 2023
DOI: 10.1101/gr.276986.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome Research, 2023. Verfasst von Varsha Poondi Krishnan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetics and Biophysics Adriano Buzzati Traverso, (IGB-ABT) CNR, Naples 80131, Italy. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Bi-allelic hypomorphic mutations in DNMT3B disrupt DNA methyltransferase activity and lead to immunodeficiency, centromeric instability, facial anomalies syndrome, type 1 (ICF1). Although several ICF1 phenotypes have been linked to abnormally hypomethylated repetitive regions, the unique genomic regions responsible for the remaining disease phenotypes remain largely uncharacterized. Here we explored two ICF1 patient–derived induced pluripotent stem cells (iPSCs) and their CRISPR-Cas9-corrected clones to determine whether DNMT3B correction can globally overcome DNA methylation defects and related changes in the epigenome. Hypomethylated regions throughout the genome are highly comparable between ICF1 iPSCs carrying different DNMT3B variants, and significantly overlap with those in ICF1 patient peripheral blood and lymphoblastoid cell lines. These regions include large CpG island domains, as well as promoters and enhancers of several lineage-specific genes, in particular immune-related, suggesting that they are premarked during early development. CRISPR-corrected ICF1 iPSCs reveal that the majority of phenotype-related hypomethylated regions reacquire normal DNA methylation levels following editing. However, at the most severely hypomethylated regions in ICF1 iPSCs, which also display the highest increases in H3K4me3 levels and/or abnormal CTCF binding, the epigenetic memory persists, and hypomethylation remains uncorrected. Overall, we demonstrate that restoring the catalytic activity of DNMT3B can reverse the majority of the aberrant ICF1 epigenome. However, a small fraction of the genome is resilient to this rescue, highlighting the challenge of reverting disease states that are due to genome-wide epigenetic perturbations. Uncovering the basis for the persistent epigenetic memory will promote the development of strategies to overcome this obstacle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Genetics and Biophysics Adriano Buzzati Traverso, (IGB-ABT) CNR, Naples 80131, Italy.
- Department of Genetics and Developmental Biology, Rappaport Faculty of Medicine and Research Institute, Technion, Haifa 31096, Israel.
- Institute for Applied Computing (IAC) "Mauro Picone", CNR, Naples 80131 Italy.
- IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Isernia 86077, Italy.
- Institute of Genetics and Biophysics Adriano Buzzati Traverso, (IGB-ABT) CNR, Naples 80131, Italy; maria.matarazzo@igb.cnr.it claudia.angelini@cnr.it seligs@technion.ac.il.
- Institute for Applied Computing (IAC) "Mauro Picone", CNR, Naples 80131 Italy; maria.matarazzo@igb.cnr.it claudia.angelini@cnr.it seligs@technion.ac.il.
ORCID-Profile: Varsha Poondi Krishnan, Shir Toubiana, Claudia Angelini, Sara Selig, Maria R Matarazzo
Zitieren
APA
Poondi Krishnan, V., Morone, B., Toubiana, S., Krzak, M., Fioriniello, S., Della Ragione, F., Strazzullo, M., Angelini, C., Selig, S., & Matarazzo, M. R. (2023). The aberrant epigenome of DNMT3B -mutated ICF1 patient iPSCs is amenable to correction, with the exception of a subset of regions with H3K4me3- and/or CTCF-based epigenetic memory. Genome Research. https://doi.org/10.1101/gr.276986.122
Vancouver
Poondi Krishnan V, Morone B, Toubiana S, Krzak M, Fioriniello S, Della Ragione F, et al. The aberrant epigenome of DNMT3B -mutated ICF1 patient iPSCs is amenable to correction, with the exception of a subset of regions with H3K4me3- and/or CTCF-based epigenetic memory. Genome Research. 2023. doi:10.1101/gr.276986.122
BibTeX
@article{PoondiKrishnan2023,
author = {Poondi Krishnan, Varsha and Morone, Barbara and Toubiana, Shir and Krzak, Monika and Fioriniello, Salvatore and Della Ragione, Floriana and Strazzullo, Maria and Angelini, Claudia and Selig, Sara and Matarazzo, Maria R},
title = {The aberrant epigenome of DNMT3B -mutated ICF1 patient iPSCs is amenable to correction, with the exception of a subset of regions with H3K4me3- and/or CTCF-based epigenetic memory},
journal = {Genome Research},
year = {2023},
doi = {10.1101/gr.276986.122}
}
EUVIMED